By Editor , 20 September 2026
Octagos Named Only Cardiac Monitoring Firm on TIME HealthTech List

Houston – September 19, 2026 -- Octagos has been named to TIME and Statista's World's Top HealthTech Companies of 2026 list, marking the only cardiac implantable electronic device (CIED) monitoring company recognized in either the inaugural 2025 ranking or the 2026 edition.

By Editor , 20 September 2026
CND Life Sciences Opens Scottsdale Innovation Lab for Neurodiagnostics R&D

Scottsdale, Ariz. – September 19, 2026 -- CND Life Sciences, Inc. has opened a new Innovation Laboratory in Scottsdale, Arizona, expanding its research and product-development capacity for neurodegenerative disease diagnostics. The facility was inaugurated with a ribbon-cutting ceremony attended by employees, community members, and key stakeholders, and operations are set to begin next week.

By Editor , 20 September 2026
Virbac H1 2026 Revenue Rises 7.4%, Confirms Upper-End Guidance

Paris – September 19, 2026 -- Virbac posted first-half 2026 revenue growth of 7.4% at constant exchange rates and currencies (CERS), lifting its adjusted EBIT margin to 18.8%, up 0.5 percentage points from H1 2025.

Companion animal segment leads growth at 10.0%, farm animal follows at 6.7%

The animal health group's Supercharge platforms, excluding Thyronorm, expanded around 12% at CERS, becoming a key driver of top-line performance. Growth split into a volume/mix effect of approximately 5.4% and a price increase of roughly 2%.

By Editor , 20 September 2026
Eterna Regeneratives Raises Seed Funding for Keratin Enamel Repair Tech

London – September 19, 2026 -- UK biotech spin-out Eterna Regeneratives has closed a seed funding round led by Hoxton Ventures and The Venture Collective to commercialize a keratin-based material that regrows tooth enamel, targeting the $43 billion global oral care market.

By Editor , 20 September 2026
DarioHealth Signs New Jersey Health Plan Covering 1.5M Lives via Amwell

New York – September 19, 2026 -- DarioHealth Corp. (NASDAQ: DRIO) has secured a new contract with one of New Jersey's largest health plans, covering approximately 1.5 million lives, through its channel partnership with Amwell. The program covering Dario's cardiometabolic suite and provider-backed care is expected to launch and begin generating revenue in the first quarter of 2027.

By Editor , 20 September 2026
Canary Speech Named to TIME's Top HealthTech Companies 2026 List

Provo, Utah – September 19, 2026 -- Canary Speech has been named to TIME and Statista's World's Top HealthTech Companies 2026 ranking, marking the second consecutive year the vocal biomarker technology firm has received the distinction.

TIME and Statista select 500 companies from thousands of HealthTech firms reviewed globally

The ranking evaluated companies across three primary data sources: Financial Performance Metrics, Reputation Analysis, and Online Engagement. The list was announced on September 17, 2026, and published on Time.com.

By Editor , 20 September 2026
CU Anschutz Study: Post-Concussion Irritability Tied to PTSD, Pain, Hearing

Aurora, Colo. – September 19, 2026 -- A new study from the University of Colorado Anschutz Marcus Institute for Brain Health finds that irritability following chronic mild traumatic brain injury (mTBI) in military veterans stems from a combination of PTSD symptoms, chronic pain and difficulty understanding speech in noisy environments, not a single psychological cause.

By Editor , 20 September 2026

Shanghai – September 19, 2026 -- 111, Inc. (NASDAQ: YI) reported a net loss of RMB31.7 million (US$4.7 million) for the second quarter of 2026, more than four times the RMB7.3 million loss posted a year earlier, as the Shanghai-based healthcare platform accelerated its shift away from an asset-heavy distribution model.